Fennec Pharmaceuticals Inc banner
F

Fennec Pharmaceuticals Inc
NASDAQ:FENC

Watchlist Manager
Fennec Pharmaceuticals Inc
NASDAQ:FENC
Watchlist
Price: 10.5 USD -1.78%
Market Cap: $364.8m

Intrinsic Value

The intrinsic value for Fennec Pharmaceuticals Inc (FENC) under the Base Case is 16.4 USD. Compared with the current market price of 10.5 USD, the stock appears Undervalued by 36% .

Based on two methods:

DCF suggests undervaluation, while multiples suggest overvaluation.

FENC Intrinsic Value
16.4 USD
Undervaluation 36%
Intrinsic Value
Price $10.5
F
Bear Case
Base Case
Bull Case
Monitor FENC
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $13.12
Get notified when the price drops into your buy zone
Intrinsic Value $16.4
Margin of Safety 20% $13.12
Current Price $10.5
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about FENC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is FENC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Fennec Pharmaceuticals Inc.

Explain Valuation
Alternatives to FENC

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

FENC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one FENC stock?

The intrinsic value for Fennec Pharmaceuticals Inc (FENC) under the Base Case is 16.4 USD.

Is FENC stock undervalued or overvalued?

Compared with the current market price of 10.5 USD, the stock appears Undervalued by 36% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett